Cargando…
An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures
The Filovirus Animal Non-Clinical Group (FANG) is a US interdepartmental and interagency group established to support and facilitate the advanced development of filovirus Medical Countermeasures (MCM), both vaccines and therapeutics. It is co-led by one representative from the Department of Defense...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497053/ https://www.ncbi.nlm.nih.gov/pubmed/23202465 http://dx.doi.org/10.3390/v4102312 |
_version_ | 1782249712164798464 |
---|---|
author | Kilgore, Nicole Nuzum, Edwin O. |
author_facet | Kilgore, Nicole Nuzum, Edwin O. |
author_sort | Kilgore, Nicole |
collection | PubMed |
description | The Filovirus Animal Non-Clinical Group (FANG) is a US interdepartmental and interagency group established to support and facilitate the advanced development of filovirus Medical Countermeasures (MCM), both vaccines and therapeutics. It is co-led by one representative from the Department of Defense (DoD), the first author, and one from the Department of Health and Human Services (HHS), the second author. The FANG membership includes operational level program staff and Subject Matter Experts (SME) from performing organizations as well as scientific staff and program managers from DoD and HHS funding and regulatory agencies. Focus areas include animal models, assays, reagents, product manufacture and characterization, and other interagency product development issues that will support Food and Drug Administration (FDA) licensure of safe and effective filovirus MCMs. The FANG continues to develop strategies to address broadly applicable and interagency product development challenges relevant to filovirus MCM development. This paper summarizes FANG structure and accomplishments and is meant to heighten community awareness of this government-led collaborative effort. |
format | Online Article Text |
id | pubmed-3497053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-34970532012-11-29 An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures Kilgore, Nicole Nuzum, Edwin O. Viruses Editorial The Filovirus Animal Non-Clinical Group (FANG) is a US interdepartmental and interagency group established to support and facilitate the advanced development of filovirus Medical Countermeasures (MCM), both vaccines and therapeutics. It is co-led by one representative from the Department of Defense (DoD), the first author, and one from the Department of Health and Human Services (HHS), the second author. The FANG membership includes operational level program staff and Subject Matter Experts (SME) from performing organizations as well as scientific staff and program managers from DoD and HHS funding and regulatory agencies. Focus areas include animal models, assays, reagents, product manufacture and characterization, and other interagency product development issues that will support Food and Drug Administration (FDA) licensure of safe and effective filovirus MCMs. The FANG continues to develop strategies to address broadly applicable and interagency product development challenges relevant to filovirus MCM development. This paper summarizes FANG structure and accomplishments and is meant to heighten community awareness of this government-led collaborative effort. MDPI 2012-10-19 /pmc/articles/PMC3497053/ /pubmed/23202465 http://dx.doi.org/10.3390/v4102312 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Editorial Kilgore, Nicole Nuzum, Edwin O. An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures |
title | An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures |
title_full | An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures |
title_fullStr | An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures |
title_full_unstemmed | An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures |
title_short | An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures |
title_sort | interagency collaboration to facilitate development of filovirus medical countermeasures |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497053/ https://www.ncbi.nlm.nih.gov/pubmed/23202465 http://dx.doi.org/10.3390/v4102312 |
work_keys_str_mv | AT kilgorenicole aninteragencycollaborationtofacilitatedevelopmentoffilovirusmedicalcountermeasures AT nuzumedwino aninteragencycollaborationtofacilitatedevelopmentoffilovirusmedicalcountermeasures AT kilgorenicole interagencycollaborationtofacilitatedevelopmentoffilovirusmedicalcountermeasures AT nuzumedwino interagencycollaborationtofacilitatedevelopmentoffilovirusmedicalcountermeasures |